Beyond weight, the glucagon receptor agonism component carries theoretical benefits for non-alcoholic fatty liver disease (NAFLD), now reclassified as metabolic dysfunction-associated steatotic liver disease (MASLD)
Emerging research also suggests they could benefit cardiovascular health , vascular diseases , and even addictive behaviors
A lot of research has been done to design agents that target the IGF family and its signaling pathway
Omega-3 fatty acids, especially DHA and EPA from fish oil, are also commonly recommended to support cognitive development and reduce inflammation
They also found that piperaquine, an anti-malarial drug, has the potential as a drug for ASD due to its ability to interact with ferroptosis-related genes [241]
Safety and tolerability data from injection studies show mild side effects (injection site reactions, headache) with no serious adverse events at therapeutic doses